Q3 Concall Highlights

SRF Q3 2022 Concall Highlights

Operational Highlights  Revenues for the quarter stood at  ₹3,345.9 as against  ₹2146.4 Cr in Q3FY21, translating growth of 55.9% YoY EBITDA margins stood at 25.7% Revenue breakup Chemical business-42.6% Packaging films-38.1 Technical textile- 16.1% Others-3.2% Launched new pharma intermediate during the quarter and successfully conducted  campaigns for 2-3 upcoming products. Achieved highest ever production in …

SRF Q3 2022 Concall Highlights Read More »

Rossari biotech Q3 2022 Concall Highlights

Operational Highlights Revenues for the quarter stood at ₹428.4Cr, up 104% from same period previous year EBITDA stood at ₹46.7 Cr translating to EBITDA margins of 10.9% PAT stood at ₹22.5 Cr with PAT margins of 5.3% Delivered steady performance during the quarter despite a challenging inflationary macro-environment Undertaking price hikes wherever possible to offset …

Rossari biotech Q3 2022 Concall Highlights Read More »